Gedeon Richter PLC (0QFP) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Gedeon Richter PLC (0QFP) has a cash flow conversion efficiency ratio of 0.050x as of September 2021. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (£42.97 Billion ≈ $57.71 Billion USD) by net assets (£864.05 Billion ≈ $1.16 Trillion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Gedeon Richter PLC stock valuation for the company's overall valuation and market capitalisation.
Gedeon Richter PLC - Cash Flow Conversion Efficiency Trend (2016–2020)
This chart illustrates how Gedeon Richter PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Gedeon Richter PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Gedeon Richter PLC ranked by their cash flow conversion efficiency. Explore Gedeon Richter PLC earnings quality ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kazia Therapeutics Ltd ADR
NASDAQ:KZIA
|
0.499x |
|
Spero Therapeutics Inc
NASDAQ:SPRO
|
-0.141x |
|
ISU Abxis Co. Ltd
KQ:086890
|
0.088x |
|
Erbud SA
WAR:ERB
|
-0.262x |
|
Rent the Runway Inc
NASDAQ:RENT
|
0.071x |
|
Bumech S.A.
WAR:BMC
|
0.034x |
|
Salazar Resources Limited
V:SRL
|
-0.016x |
|
Northview Acquisition Corp
NASDAQ:NVAC
|
0.029x |
Annual Cash Flow Conversion Efficiency for Gedeon Richter PLC (2016–2020)
The table below shows the annual cash flow conversion efficiency of Gedeon Richter PLC from 2016 to 2020. View today's stock price for Gedeon Richter PLC for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2020-12-31 | £806.96 Billion ≈ $1.08 Trillion |
£133.52 Billion ≈ $179.31 Billion |
0.165x | +20.96% |
| 2019-12-31 | £717.98 Billion ≈ $964.18 Billion |
£98.21 Billion ≈ $131.89 Billion |
0.137x | -7.27% |
| 2018-12-31 | £680.18 Billion ≈ $913.43 Billion |
£100.34 Billion ≈ $134.75 Billion |
0.148x | +16.14% |
| 2017-12-31 | £659.33 Billion ≈ $885.42 Billion |
£83.75 Billion ≈ $112.46 Billion |
0.127x | +11.24% |
| 2016-12-31 | £678.00 Billion ≈ $910.49 Billion |
£77.42 Billion ≈ $103.97 Billion |
0.114x | -- |
About Gedeon Richter PLC
Gedeon Richter PLC researches, develops, manufactures, markets, and sells pharmaceutical products. It offers women's healthcare products for contraceptives, endometriosis, fertility, menopause, vaginal infections, and uterine fibroids; and Femtech, a digital therapeutic solution to enhance women's lives. It also provides central nervous system products, such as products for the treatment of chron… Read more